Amgen Inc. and Astellas Pharma agreed to pay settlements to resolve allegations they violated the False Claims Act by conspiring with two co-pay foundations to create funds that acted to benefit patients taking their drugs, making their donations kickbacks, the Justice Department said in a statement.
Amgen and Astellas each entered five-year corporate integrity agreements with OIG as part of their respective settlements.
Link to statement is here.
©2019 Bloomberg L.P. All rights reserved. Used with permission
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.